Global & Disaster Medicine

Doctors Without Borders will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine

November 21st, 2017

MSF

“…..The U.S.-based drug corporation’s unmerited patent prevents vaccine manufacturers in India from developing and marketing PCV13 until 2026, depriving countless children of the opportunity to be protected against pneumonia, which kills 2,500 kids per day…..There are currently only two companies that make a pneumonia vaccine, Pfizer (PCV13) and GlaxoSmithKline (PCV10). These companies have already made more than $40 billion on their vaccines and have consistently fought to prevent others from entering the market with lower-price versions……”

 

This entry was posted on Tuesday, November 21st, 2017 at 3:41 pm and is filed under Global Health, Humanitarian, Kids-Infants .
You can follow any responses to this entry through the RSS 2.0 feed.   Both comments and pings are currently closed.

Comments are closed.

Categories

Recent Posts

Archives

Admin